Nova Scotia opens vaccine to 50-to-54 age group as testing backlog reduced

Powered by Pure, Scopus & Elsevier Fingerprint Engine™

All content on this site: Copyright © 2025 Pure University (For Demo Only), its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

Log in to Pure

About web accessibility

Report vulnerability